Current status of imaging for adrenal malignant involvement

Cancer Treatment and Research

Volumn 143, Issue , 2008, Pages 319-329

  Blake, Michael A ^a   Kalra, Mannudeep K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL GLAND; ADRENAL TUMOR; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48249146577     PISSN: 09273042     EISSN: 25098497     Source Type: Book Series    
DOI: 10.1007/978-0-387-75587-8_13     Document Type: Article

References (35)

1. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149:273-85.
2. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign from malignant adrenal masses: Multi-detector row CT protocol with 10-minute delay. Radiology 2006:578-585.
3. Szolar DH, Korobkin M, Reittner P, et al. Adrenocortical carcinomas and adrenal pheochro-mocytomas: Mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005; 234:479-85.
4. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: Characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222:629-33.
5. Lee M, Hahn P, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-8.
6. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonade-nomas using CT attenuation values. AJR Am J Roentgenol 1996; 166:531-6.
7. Singer A, Obuchowski N, Einstein D, Paushter D. Metastasis or adenoma? Computed tomo-graphic evaluation of the adrenal mass. Cleve Clin J Med 1994; 61:200-5.
8. van Erkel A, van Gils A, Lequin M, Kruitwagen C, Bloem J, Falke T. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 1994; 18:432-8.
9. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: An analysis of the CT literature. AJR Am J Roentgenol 1998; 171:201-4.
10. Choyke P. ACR Appropriateness Criteria on Incidentally Discovered Adrenal Masses. J Am Coll Radiol 2006; 3:498-504.
11. Korobkin MF, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996; 200:737-42.
12. Korobkin MF, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170: 747-52.
13. Blake MA, Krishnamoorthy SK, Boland GW, et al. Low-density pheochromocytoma on CT: A mimicker of adrenal adenoma. AJR Am J Roentgenol 2003; 181:1663-8.
14. Jain RK, Munn LL, Fukumura D. Dissecting tumor pathophysiology using intravital microscopy. Nat Rev Cancer 2002; 2:266-76.
15. Boland GW, Hahn PF, Pena C, Mueller PR. Adrenal masses: Characterization with delayed contrast-enhanced CT. Radiology 1997; 202:693-6.
16. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 2000; 175:1411-5.
17. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: Use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217:798-802.
18. Young WF. The incidentally discovered adrenal mass. N Eng J Med 2007; 356:601-10.
19. Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP. Adrenal masses: CT characterization with histogram analysis method. Radiology 2003; 228:735-42.
20. Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR. CT histogram analysis in pathologically proven adrenal masses. AJR Am J Roentgenol 2006; 187:191-6.
21. Blake MA, Kalra MK, Maher MM, et al. Pheochromocytoma: An imaging chameleon. Radiographics 2004; 24:S87-99.
22. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 2004; 183:215-9.
23. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. Radiographics 2001; 21:995-1012.
24. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: Does it still have a role? Radiology 2004; 231:711-716.
25. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 194:131-4.
26. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: Characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 2006; 238:970-7.
27. Kumar R, Xiu Y, Yu JQ, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45:2058-62.
28. Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the Evaluation of Adrenal Masses. J Nucl Med 2006; 47:32-37.
29. Erasmus JJ, Patz EF, Jr., McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997; 168:1357-60.
30. Minn H, Salonen A, Friberg J, et al. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med 2004; 45:972-9.
31. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: Update in diagnosis and. Endocr Rev 2004; 25:309-40.
32. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003; 138:424-9.
33. Schteingart DE, Doherty GM, Gauger PG, et al. Management of patients with adrenal cancer: Recommendations of an international consensus conference. Endocr Relat Cancer 2005; 12:667-80.
34. Stone J. Incidentalomas-clinical correlation and translational science required. N Engl J Med 2006; 354:2748-9.
35. Blake MA, Sweeney AT, Kalra MK, Maher M. Collision Adrenal Tumors on PET/CT. Am J Roentgenol. 183(3):864-5, 2004.